NCT03067662

Brief Summary

A few, small randomized controlled trials have investigated the effects of exercise on blood glucose levels in women with gestational diabetes (GDM), with inconsistent results. To assess the effects of supervised exercise in women with GDM, 48 women with gestational diabetes, diagnosed between the 18th and 28th week of gestation, will be recruited, after exclusion of subjects with contraindications to exercise. These subjects will be randomly assigned to two groups: structured exercise intervention or standard care. Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (heart rate reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (increasing 2 min/week). Women in the control group will receive standard diet and physical exercise recommendations. In all women, clinical, metabolic and anthropometric features will be assessed before, during and at the end of the study. Newborn data will also be collected.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2012

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

February 3, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 1, 2017

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

May 6, 2021

Status Verified

May 1, 2021

Enrollment Period

9.8 years

First QC Date

February 3, 2017

Last Update Submit

May 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in fasting plasma glucose levels (mg/dL)

    Before intervention and at 35-37 week of gestation

Secondary Outcomes (28)

  • Change in body weight (kg)

    Before intervention and at 35-37 week of gestation

  • Change in body mass index (kg/m^2, weight in kilograms, height in meters)

    Before intervention and at 35-37 week of gestation

  • Change in blood pressure (mmHg)

    Before intervention and at 35-37 week of gestation

  • Change in heart rate (HR, beats per minute)

    Before intervention and at 35-37 week of gestation

  • Dosage of insulin therapy, if required

    Before intervention and at 35-37 week of gestation

  • +23 more secondary outcomes

Study Arms (2)

Supervised exercise intervention

EXPERIMENTAL

Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (Heart Rate Reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (by increasing 2 min/week).

Other: Aerobic exercise

Current standard of care

NO INTERVENTION

Women in the control group will receive standard physical exercise recommendations.

Interventions

Supervised exercise intervention

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton pregnancy,
  • Gestational diabetes diagnosis between 18th and 28th week of gestation,
  • Caucasian.

You may not qualify if:

  • Hemodynamically significant heart disease,
  • Restricted lung disease,
  • Incompetent cervix/cerclage,
  • Persistent second or third trimester bleeding,
  • Placenta previa,
  • Threatened preterm labor,
  • Ruptured membranes,
  • Preeclampsia,
  • Hypertension,
  • Severe anemia,
  • Cardiac arrhythmias,
  • History of epilepsy,
  • Chronic bronchitis,
  • Orthopedic limitations,
  • Overt hyperthyroidism/ hypothyroidism,
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endocrinology, Diabetes and Metabolism Section, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona

Verona, 37126, Italy

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Paolo Moghetti, MD, PhD

    University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Paolo Moghetti, MD, PhD

CONTACT

Silvia DonĂ , MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Prof.

Study Record Dates

First Submitted

February 3, 2017

First Posted

March 1, 2017

Study Start

September 27, 2012

Primary Completion

June 30, 2022

Study Completion

December 30, 2022

Last Updated

May 6, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations